All Infectious Disease articles – Page 34
-
NewsUS approves world’s first vaccine to protect honey bees
The world’s first vaccine for honey bees has been approved by authorities in the US.
-
NewsScientists test Raman spectroscopy as diagnostic tool for Lyme disease
Two Texas A&M University scientists are developing a test for Lyme disease that’s both more accurate and more efficient than the current test.
-
NewsOlfactory viral inflammation linked to accelerated onset of Alzheimer’s disease
Viruses can inflame and disrupt connections between the olfactory system, which governs the sense of smell, and the part of the brain associated with memory and learning, possibly accelerating the onset of Alzheimer’s disease, according to a new study.
-
NewsStudy reveals how plague spreads through wild rodent populations
Mathematical modeling reveals how fleas with early-stage Yersinia pestis infections are insufficient to drive epizootic outbreaks but can help promote a low level of enzootic plague.
-
NewsScientists identify infection-halting compound that can target hosts, not viruses
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
-
NewsPhase 2 trial of Ebola vaccines yields promising results
An international team of scientists has published the results of a large-scale randomized clinical trial in West Africa which confirms the safety of three vaccine regimens for Ebola and suggests an immune response is induced and maintained for up to 12 months.
-
NewsResearchers infect ‘brain in a dish’ in pursuit of Zika antivirals
A University of Queensland-led project has used a ‘brain in a dish’ to study the effects of the Zika virus, taking research a step closer towards developing drugs to combat the infection.
-
-
NewsVaccine for Lyme disease one step closer with promising six-month results
A vaccine for Lyme disease is one step closer after Pfizer Inc and Valneva SE reported positive results in their antibody persistence data six months after completing a three-dose or two-dose schdule in children and adults with vaccine candidate VLA15.
-
News New virus discovered in Swiss ticks
Researchers from the Institute of Virology at the University of Zurich (UZH) have detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
-
NewsResearchers find new viral entryway into host cells for Covid-19
A University of Ottawa-led team has found a new viral entry for SARS-CoV-2, suggesting it may be able to use proteins to infect a wider range of cells.
-
NewsNew £1.7m containment facility will help prepare for future pandemics
A £1.7m laboratory building which will investigate infectious diseases has opened at the University of Warwick – helping to tackle some of the most globally important human diseases and prepare for pandemics of the future.
-
NewsAntibiotics could be given to children at UK schools affected by Strep A: government
Antibiotics could be given to children at schools affected by Strep A to stop the spread of the infection, schools minister Nick Gibb has suggested.
-
NewsPathogen capture method speeds up ID in children with bloodstream infections
Researchers have developed a fast and highly efficient engineered pathogen capture method which shortcuts the accurate detection of pathogens in small blood samples, potentially saving lives.
-
NewsStudy of simple acoziborole regime raises hope for elimination of sleeping sickness in Africa
The Drugs for Neglected Diseases initiative (DNDi) and Sanofi have announced treatment success rates of up to 95% from a Phase II/III study investigating the safety and efficacy of single-dose acoziborole, a potentially transformative investigational treatment for sleeping sickness.
-
NewsToxic bacteria find floating homes on microfibres in the Mediterranean Sea
Almost 200 species of bacteria have colonized microfibres in the Mediterranean Sea, including one that causes food poisoning in humans, according to a new study.
-
NewsBiovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).
-
NewsResearcher receives €1.5m from ERC to probe insecticide resistance in malaria transmission
Dr Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of €1.5 million for her research on the infectious disease malaria.
-
NewsHospitals are riskier than farms when it comes to superbug transmission - but beware your pet
A deadly drug resistant bacterium that rivals MRSA is found in livestock, pets and the wider environment, but is rarely transmitted to humans through this route, scientists have found.
-
NewsGut parasites could aid the spread of respiratory bugs in rabbits
Researchers have found that co-infection with one or more gut parasites increases shedding of Bordetella bacterium and could increase onward transmission.